Ticker Details
Stoke Therapeutics, Inc.
IPO Date:	June 17, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.08B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.67 | 3.30%
Avg Daily Range (30 D):	$1.12 | 3.32%
Avg Daily Range (90 D):	$1.04 | 3.21%

Institutional Daily Volume
Avg Daily Volume:	.33M
Avg Daily Volume (30 D):	.59M
Avg Daily Volume (90 D):	.56M

Trade Size
Avg Trade Size (Sh.):	72
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	1,512
Avg Institutional Trade:	$2.2M
Avg Institutional Trade (30 D):	$4.28M
Avg Institutional Trade (90 D):	$3.47M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.07M
Avg Closing Trade (30 D):	$4.53M
Avg Closing Trade (90 D):	$4.52M
Avg Closing Volume:	101.7K

News

Jun 28, 2024 @ 4:01 PM A Closer Look at 5 Analyst Recommendations For Sto... Source: Benzinga Insights

May 6, 2024 @ 3:01 PM Analyst Expectations For Stoke Therapeutics's Futu... Source: Benzinga Insights

May 6, 2024 @ 12:05 PM Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, T... Source: Zacks Equity Research

Apr 29, 2024 @ 2:00 PM Earnings Preview: Axsome Therapeutics (AXSM) Q1 Ea... Source: Zacks Equity Research

Apr 25, 2024 @ 2:01 PM Earnings Preview: Stoke Therapeutics, Inc. (STOK) ... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.12	$-1	$-.12
Diluted EPS	$-.12	$-.97	$-.12
Revenue	$184.42M	$1.4M	$184.42M
Gross Profit
Net Income / Loss	$-6.89M	$-57.93M	$-6.89M
Operating Income / Loss	$-20.59M	$-61.44M	$-20.59M
Cost of Revenue
Net Cash Flow	$-43.84M	$.83M	$-43.84M
PE Ratio

Splits
Jun 06, 2019	10:99